DNA methylation markers for early detection of women’s cancer: promise and challenges

References

• American Cancer Society, GA, USA: Cancer Facts and Figures 2013 . www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf
   Google Scholar
• European Commission´s Eurostat, Luxembourg: Health Statistics. http://epp.eurostat.ec.europa.eu/
   Google Scholar
• Weaver DL , AshikagaT , KragDNet al. Effect of occult metastases on survival in node-negative breast cancer . N. Engl. J. Med.364 ( 5 ), 412 – 421 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Rosner D , LaneWW . Predicting recurrence in axillary-node negative breast cancer patients . Breast Cancer Res. Treat.25 ( 2 ), 127 – 139 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Jemal A , SiegelR , WardE , HaoY , XuJ , ThunMJ . Cancer statistics, 2009 . CA Cancer J. Clin.59 ( 4 ), 225 – 249 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ozols RF . Systemic therapy for ovarian cancer: current status and new treatments . Semin. Oncol.33 ( 2 Suppl. 6 ), S3 – S11 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Sorosky JI . Endometrial cancer . Obstet. Gynecol.111 ( 2 Pt 1 ), 436 – 447 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Carey MS , GawlikC , Fung-Kee-FungM , ChambersA , OliverT . Cancer Care Ontario Practice Guidelines Initiative Gynecology Cancer Disease Site Group. Systematic review of systemic therapy for advanced or recurrent endometrial cancer . Gynecol. Oncol.101 ( 1 ), 158 – 167 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Chaudhry P , AsselinE . Resistance to chemotherapy and hormone therapy in endometrial cancer . Endocr. Relat. Cancer16 ( 2 ), 363 – 380 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Arbyn M , AnttilaA , JordanJet al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition – summary document . Ann. Oncol.21 , 448 – 458 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Buys SS , PartridgeE , BlackAet al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial . JAMA305 ( 22 ), 2295 – 2303 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Menon U , Gentry-MaharajA , HallettRet al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) . Lancet Oncol.10 ( 4 ), 327 – 340 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Jacobs I , BastRCJr . TheCA 125 Tumour-associated antigen: a review of the literature . Hum. Reprod.4 ( 1 ), 1 – 12 ( 1989 ).
   PubMed Web of Science ®Google Scholar
• Moore RG , McMeekinDS , BrownAKet al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass . Gynecol. Oncol.112 ( 1 ), 40 – 46 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Jacobs I , OramD , FairbanksJ , TurnerJ , FrostC , GrudzinskasJG . A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer . Br. J. Obstet. Gynaecol.97 ( 10 ), 922 – 929 ( 1990 ).
   PubMedGoogle Scholar
• Geomini P , KruitwagenR , BremerGL , CnossenJ , MolBW . The accuracy of risk scores in predicting ovarian malignancy: a systematic review . Obstet. Gynecol.113 ( 2 Pt 1 ), 384 – 394 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Yazbek J , RajuSK , Ben-NagiJ , HollandTK , HillabyK , JurkovicD . Effect of quality of gynaecological ultrasonography on management of patients with suspected ovarian cancer: a randomised controlled trial . Lancet Oncol.9 ( 2 ), 124 – 131 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Welch HG , FrankelBA . Likelihood that a woman with screen-detected breast cancer has had her ‘life saved’ by that screening . Arch. Intern. Med.171 , 2043 – 2046 ( 2011 ).
   PubMedGoogle Scholar
• Mook S , Van’t VeerLJ , RutgersEJet al. Independent prognostic value of screen detection in invasive breast cancer . J. Natl Cancer Inst.103 , 585 – 597 ( 2011 ).
   PubMedGoogle Scholar
• Zahl PH , GotzschePC , MaehlenJ . Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study . Lancet Oncol.12 , 1118 – 1124 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Jorgensen KJ , GotzschePC . Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends . BMJ339 , b2587 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Warner E . Clinical practice. Breast-cancer screening . N. Engl. J. Med.365 , 1025 – 1032 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Gigerenzer G , MataJ , FrankR . Public knowledge of benefits of breast and prostate cancer screening in Europe . J. Natl Cancer Inst.101 , 1216 – 1220 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Siegel R , NaishadhamD , JemalA . Cancer statistics, 2013 . CA Cancer J. Clin.63 ( 1 ), 11 – 30 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pessoa JN , FreitasAC , GuimaraesRA , LimaJ , Dos ReisHL , FilhoAC . Endometrial assessment: when is it necessary?J. Clin. Med. Res.6 ( 1 ), 21 – 25 ( 2014 ).
   PubMedGoogle Scholar
• Tavasolli FA , DevileeP . WHO Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs.IARC Press , Lyon, France ( 2004 ).
   Google Scholar
• Langer RD , PierceJJ , O’HanlanKAet al. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial . N. Engl. J. Med.337 ( 25 ), 1792 – 1798 ( 1997 ).
   PubMedGoogle Scholar
• Fleischer AC , WheelerJE , LindsayIet al. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms . Am. J. Obstet. Gynecol.184 ( 2 ), 70 – 75 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Henry NL , HayesDF . Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer . Oncologist11 ( 6 ), 541 – 552 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Pepe MS , EtzioniR , FengZet al. Phases of biomarker development for early detection of cancer . J. Natl Cancer Inst.93 , 1054 – 1061 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Teschendorff AE , MenonU , Gentry-MaharajAet al. An epigenetic signature in peripheral blood predicts active ovarian cancer . PLoS ONE4 , e8274 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Andriole GL , CrawfordED , GrubbRLet al. Mortality results from a randomized prostate-cancer screening trial . N. Engl. J. Med.360 , 1310 – 1319 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Buys SS , PartridgeE , BlackAet al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial . JAMA305 , 2295 – 2303 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Schroder FH , HugossonJ , RoobolMJet al. Screening and prostate-cancer mortality in a randomized European study . N. Engl. J. Med.360 , 1320 – 1328 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Jones PA , BaylinSB . The epigenomics of cancer . Cell128 , 683 – 692 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Paredes M , EstellerM . Cancer epigenetics reaches mainstream oncology . Nat. Med.17 , 330 – 339 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Widschwendter M , FieglH , EgleDet al. Epigenetic stem cell signature in cancer . Nat. Genet.39 ( 2 ), 157 – 158 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Gormally E , CabouxE , VineisP , HainautP . Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance . Mutat. Res.635 , 105 – 117 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Weisenberger DJ , TrinhBN , CampanMet al. DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight . Nucleic Acids Res.36 , 4689 – 4698 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Weber M , DaviesJJ , WittigDet al. 2005. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells . Nat. Genet.37 , 853 – 862 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Brinkman AB , SimmerF , MaK , KaanA , ZhuJ , StunnenbergHG . Whole-genome DNA methylation profiling using MethylCap-seq . Methods52 , 232 – 236 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Rauch T , PfeiferGP . Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer . Lab. Invest.85 ( 9 ), 1172 – 1180 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Serre D , LeeBH , TingAH . MBD-isolated genome sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome . Nucleic Acids Res.38 ( 2 ), 391 – 399 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bock CE , TomazouEM , BrinkmanABet al. Quantitative comparison of genome-wide DNA methylation mapping technologies . Nat. Biotechnol.28 ( 10 ), 1106 – 1114 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bock C . Analysing and interpreting DNA methylation data . Nat. Rev. Genet.13 ( 10 ), 705 – 719 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• The Cancer Genome Atlas . http://cancergenome.nih.gov/  
   Google Scholar
• Clark SJ , HarrisonJ , PaulCL , FrommerM . High sensitivity mapping of methylated cytosines . Nucleic Acids Res.22 , 2990 – 2997 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Frommer M , McDonaldLE , MillarDSet al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands . Proc. Natl Acad. Sci. USA89 , 1827 – 1831 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Harris RA , WangT , CoarfaCet al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications . Nat. Biotechnol.28 ( 10 ), 1097 – 1105 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Gu H , SmithZD , BockC , BoyleP , GnirkeA , MeissnerA . Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling . Nat. Protoc.6 , 468 – 481 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chatterjee A , RodgerEJ , StockwellPA , WeeksRJ , MorisonIM . Technical considerations for reduced representation bisulfite sequencing with multiplexed libraries . J. Biomed. Biotechnol.1 – 8 ( 2012 ) ( 2012 ).
   PubMedGoogle Scholar
• Gu H , BockC , MikkelsenTS . Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution . Nat. Methods7 , 133 – 136 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ellinger J , El KassemN , HeukampLCet al. Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer . J. Urol.179 , 346 – 352 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Quail MA , SmithM , CouplandPet al. A tale of three next generation sequencing platforms: comparison of Ion torrent, pacific biosciences and illumina MiSeq sequencers . BMC Genomics13 , 341 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mardis ER . A decade’s perspective on DNA sequencing technology . Nature470 , 198 – 203 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Illumina . www.illumina.com  
   Google Scholar
• Herman JG , GraffJR , MyöhänenS , NelkinBD , BaylinSB . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands . Proc. Natl Acad. Sci. USA93 , 9821 – 6982 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Eads CA , DanenbergKD , KawakamiKet al. MethyLight: a high-throughput assay to measure DNA methylation . Nucleic Acids Res.28 , E32 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Weisenberger DJ , TrinhBN , CampanMet al. DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight . Nucleic Acids Res.36 , 4689 – 4698 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Zimmermann B , GrillS , HolzgreveW , ZhongXY , JacksonLG , HahnS . Digital PCR: a powerful new tool for noninvasive prenatal diagnosis?Prenat. Diagn.28 , 1087 – 1093 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hindson CM , ChevilletJR , BriggsHAet al. Absolute quantification by droplet digital PCR versus analog real-time PCR . Nat. Methods10 , 1003 – 1005 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Varley KE , MitraRD . Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples . Genome Res.20 , 1279 – 1287 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kinde I , WuJ , PapadopoulosN , KinzlerKW , VogelsteinB . Detection and quantification of rare mutations with massively parallel sequencing . Proc. Natl Acad. Sci. USA108 , 9530 – 9535 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lee da E , KimSY , LimJH , ParkSY , RyuHM . Non-invasive prenatal testing of trisomy 18 by an epigenetic marker in first trimester maternal plasma . PLoS ONE8 ( 11 ), e78136 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network , WeinsteinJN , CollinsonEAet al.The Cancer Genome Atlas Pan-Cancer Analysis Project . Nat. Genet.45 ( 10 ), 1113 – 1120 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Dedeurwaerder S , DefranceM , CalonneE , DenisH , SotiriouC , FuksF . Evaluation of the infinium methylation 450K technology . Epigenomics3 ( 6 ), 771 – 784 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Maksimovic J , GordonL , OshlackA . SWAN: Subset-quantile within array normalization for Illumina Infinium Human Methylation450 BeadChips . Genome Biol.13 ( 6 ), R44 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Marabita F , AlmgrenM , LindholmMEet al. An evaluation of analysis pipelines for DNA methylation profiling using the Illumina Human Methylation450 BeadChip platform . Epigenetics8 ( 3 ), 333 – 346 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Teschendorff AE , MarabitaF , LechnerMet al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data . Bioinformatics29 ( 2 ), 189 – 196 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chatterjee A , StockwellPA , RodgerEJ , MorisonIM . Comparison of alignment software for genome-wide bisulphite sequence data . Nucleic Acids Res.40 ( 10 ), e79 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Chen PY , CokusSJ , PellegriniM . BS Seeker: precise mapping for bisulfite sequencing . BMC Bioinformatics11 , 203 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Jaffe AE , MurakamiP , LeeHet al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies . Int. J. Epidemiol.41 ( 1 ), 200 – 209 ( 2012 ).
   PubMed Web of Science ®Google Scholar